Bristol Congenital Heart Centre, Bristol Royal Hospital for Children and Bristol Royal Infirmary, Avon, UK.
Arch Dis Child. 2011 Jan;96(1):21-4. doi: 10.1136/adc.2010.188227. Epub 2010 Nov 2.
Sudden cardiac death is the most common cause of mortality in young athletes. In some of these, the final pathway is arrhythmia. The authors aimed to identify the incidence, diagnosis and management of athletes undergoing investigation and intervention for cardiac arrhythmias.
Retrospective analysis of all patients between 10 and 17 years presenting to a supra-regional paediatric cardiac unit for investigation and intervention for a cardiac arrhythmia. Elite athletes (county and national level) were identified from the departmental clinical and arrhythmia databases (October 1997-2007). Patients with significant congenital heart disease were excluded.
From 657 patients undergoing 680 interventions, 324 were excluded. From the remaining 333 we identified 11 elite athletes - football (n=3), martial arts (n=2), rugby (n=2), triple jump, netball, canoeing, and motor sport (n=1). Presenting symptoms included palpitations (n=8) and syncope (n=1). Two were asymptomatic and investigated following routine screening. Diagnoses included atrioventricular (AV) re-entry tachycardia (n=3), AV node re-entry tachycardia (n=4), complete heart block (n=1), sinus node dysfunction (n=1), vasovagal syncope (n=1) and pre-excited atrial fibrillation (n=1). Arrhythmia interventions included implantable loop recorder (n=2), diagnostic electrophysiology study (n=9), including radiofrequency ablation (n=5), cryoablation (n=2) and pacemaker implantation (n=2). Following intervention, 10 children returned to competitive sport. There were no deaths. No child required long-term medication post-intervention.
Of the young competitive athletes identified from the authors' study, there was a high incidence of significant arrhythmias. Intervention is usually successful and most athletes return to elite sport without the need for long-term medication.
心脏性猝死是年轻运动员死亡的最常见原因。在其中一些病例中,最终途径是心律失常。作者旨在确定因心律失常接受检查和干预的运动员的发病率、诊断和管理。
对因心律失常在一家地区性儿科心脏中心接受检查和干预的 10 至 17 岁患者进行回顾性分析。从科室临床和心律失常数据库中确定精英运动员(县和国家级)(1997 年 10 月至 2007 年)。排除患有严重先天性心脏病的患者。
在 657 名接受 680 次干预的患者中,有 324 名被排除。在其余的 333 名患者中,我们发现了 11 名精英运动员-足球(n=3)、武术(n=2)、橄榄球(n=2)、三级跳远、无挡板篮球、皮划艇和赛车(n=1)。症状包括心悸(n=8)和晕厥(n=1)。有 2 名无症状患者在常规筛查后接受了检查。诊断包括房室(AV)折返性心动过速(n=3)、房室结折返性心动过速(n=4)、完全性心脏阻滞(n=1)、窦房结功能障碍(n=1)、血管迷走性晕厥(n=1)和预激性心房颤动(n=1)。心律失常干预包括植入式环路记录器(n=2)、诊断性电生理研究(n=9),包括射频消融(n=5)、冷冻消融(n=2)和起搏器植入(n=2)。干预后,10 名儿童重返竞技运动。没有死亡。没有儿童在干预后需要长期用药。
在作者的研究中确定的年轻竞技运动员中,心律失常的发病率很高。干预通常是成功的,大多数运动员无需长期用药即可重返精英运动。